What is a good alternative for diltiazem 180mg Extended Release?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Alternatives for Diltiazem 180mg Extended Release

For patients currently taking diltiazem 180mg ER, the best alternative is verapamil extended-release, starting at 180mg once daily in the morning. 1 This provides similar pharmacological effects while maintaining the once-daily dosing convenience.

First-Line Alternatives

Non-dihydropyridine Calcium Channel Blockers

  • Verapamil ER:
    • Starting dose: 180mg once daily in the morning 1
    • Can be titrated up to 240mg daily if needed
    • Provides similar heart rate control and anti-anginal effects as diltiazem
    • Comparable efficacy in hypertrophic cardiomyopathy 2

Beta-Blockers

  • Excellent alternatives when diltiazem is discontinued:
    • Metoprolol succinate: 50mg once daily (can be titrated up to 400mg daily) 3
    • Metoprolol tartrate: 25mg twice daily (can be titrated up to 200mg twice daily) 3
    • Carvedilol: 3.125-6.25mg twice daily (titrate as needed)

Clinical Decision Algorithm

  1. If patient has stable angina or hypertension:

    • First choice: Verapamil ER 180mg daily 1
    • Second choice: Beta-blocker (metoprolol or carvedilol) 3
  2. If patient has atrial fibrillation/flutter:

    • First choice: Beta-blocker 3
    • Second choice: Verapamil ER (if beta-blockers contraindicated) 3
  3. If patient has hypertrophic cardiomyopathy:

    • First choice: Non-vasodilating beta-blocker 3
    • Second choice: Verapamil ER (shown to have comparable effects to diltiazem) 2
  4. If patient has supraventricular tachycardia:

    • First choice: Beta-blocker 3
    • Second choice: Verapamil ER 3

Important Considerations

Cautions When Switching

  • Avoid combining verapamil with beta-blockers due to risk of severe bradycardia, heart block, or heart failure 3
  • Avoid dihydropyridine CCBs alone (like nifedipine, amlodipine) in patients with angina without concomitant beta-blockade 3
  • Monitor closely during transition, especially in elderly patients or those with heart failure

Contraindications for Verapamil

  • Severe left ventricular dysfunction
  • Hypotension
  • Sick sinus syndrome or high-degree AV block without pacemaker
  • Concomitant use with CYP3A4 substrates (may increase drug levels) 4

Special Populations

  • Elderly patients: Consider starting with lower doses of verapamil (120mg daily)
  • Patients with heart failure: Avoid both diltiazem and verapamil; use beta-blockers instead 3
  • Patients with obstructive HCM and severe symptoms: Both verapamil and diltiazem may be harmful 3

Monitoring After Switching

  • Blood pressure and heart rate within 1-2 weeks
  • Symptoms of bradycardia or hypotension
  • If transitioning to beta-blockers, monitor for bronchospasm in susceptible patients

Remember that when switching from diltiazem ER to verapamil ER, the total daily dose in milligrams can generally remain the same 1, making this a convenient and effective alternative that maintains similar pharmacological properties.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.